Lastly, to evaluate whether the epigenetic reprogramming mediated by Phf19 result in augmented antitumor function we adoptively transferred pmel-1 cells overexpressing Phf19, Phf19mut, or Thy1.1 into tumor-bearing mice in conjunction with administration of gp100-VV and IL-2. This evidence concerns the gene PHF19 and neoplasm.